Skip to main content

Table 3 Hematologic and non-hematologic toxic events

From: Predictive significance of FGFR4 p.G388R polymorphism in metastatic colorectal cancer patients receiving trifluridine/tipiracil (TAS-102) treatment

Toxicity

No

%

Alopecia

  

 G1/G2

8

17.0

 G3

2

4.3

Anemia

  

 G1/G2

21

44.7

 G3

5

10.6

AST/ALT increase

  

 G1/G2

8

17.0

 G3

2

4.3

Fatigue

  

 G1/G2

26

55.3

 G3

8

17.0

Diarrhea

  

 G1/G2

22

46.8

 G3

4

8.5

Nausea/Vomiting

  

 G1/G2

18

38.3

 G3

1

2.1

Neutropenia

  

 G1/G2

18

38.3

 G3

14

29.8

 G4

2

4.2

Stomatitis

  

 G1/G2

18

38.3

 G3

2

4.2

Thrombocytopenia

  

 G1/G2

9

19.1

 G3

2

4.2